Skip to main content

Table 3 Study design and SUD assessment in k = 9 studies

From: Can deep transcranial magnetic stimulation (DTMS) be used to treat substance use disorders (SUD)? A systematic review

Study

SUD assessment

Acute (after daily DTMS) assessment

Last follow-up assessmenta

Treatment strategyb

Study design

Study groups

Alcohol

 Rapinesi et al., 2013 [17]

OCDS

Session 20

6 months

add-on

open-label (case study)

1 group: DTMS

 Rapinesi et al., 2014 [19]

OCDS

Session 20

12 months

add-on

open-label (case study)

1 group: DTMS

 Ceccanti et al., 2015 [20]

VAS, TLFB, blood prolactin

Session 10

2–3 months

monotherapy

RCT

2 groups (both with cue conditionc): DTMS vs. sham

 Girardi et al., 2015 [21]

OCDS

Session 20

6 months

add-on

open-label

2 groups: DTMS vs. STD (no DTMS)

 Rapinesi et al., 2015 [22]

OCDS

Session 20

6 months

add-on

open-label

2 groups: DTMS (MDD + AUD) vs. DTMS (MDD)

 Addolorato et al., 2017 [25]

OCDS, ADS, TLFB, SPECT

Session 12

–

monotherapy

RCT

3 groups: DTMS vs. sham vs. healthy (no DTMS)

Nicotine

 Dinur-Klein et al., 2014 [18]

FTND, sTCQ, urine analysis

Session 13

6 months

monotherapy

RCT

6 groups (each with or without cue conditionc): DTMS (10 Hz) vs. DTMS (1 Hz) vs. sham

Cocaine

 Bolloni et al., 2016 [24]

Hair analysis

Session 12

6 months

monotherapy

RCT

2 groups: DTMS vs. sham

 Rapinesi et al., 2016 [23]

VAS

Session 12

2 months

add-on

open-label

1 group: DTMS

  1. aThere was no maintenance DTMS treatment during the follow-up phases
  2. bAdd-on means that DTMS was administered in addition to concurrent pharmacotherapy
  3. cThe cue condition consisted of a substance-related stimulus (e.g. raising a glass filled with a favourite alcoholic drink) prior to DTMS
  4. ADS Alcohol Dependence Scale [41], DTMS deep transcranial magnetic stimulation, FTND Fagerström Test for Nicotine Dependence [42], HDRS Hamilton Depression Rating Scale [43], k number of studies, OCDS Obsessive Compulsive Drinking Scale [44], RCT double-blind randomised controlled trial with inactive sham control group, SDT standard drug treatment, SPECT single photon emission computed tomography, sTCQ the short Tobacco Craving Questionnaire [45], SUD substance use disorder, TLFB Timeline Followback Interview (assessment of consumption) [46], VAS visual analogue scale for craving [47]